Adult Nodular Sclerosis Hodgkin Lymphoma Completed Phase 2 Trials for Ifosfamide (DB01181)

IndicationStatusPhase
DBCOND0030887 (Adult Nodular Sclerosis Hodgkin Lymphoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00381940Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous TherapyTreatment